Posted On: Wednesday, March 11th, 2015
AVI presents a ‘Lunch & Learn’ on the topic of Hepatitis C for Healthcare and Service Providers. They will cover the basics of hepatitis C including testing, transmission, and community resources, followed by an update on current and upcoming treatments provided by treatment nurses. Light lunch and refreshments provided. Victoria: Wednesday March 25th 12:00pm-2:00pm Access… Read more »
Posted On: Wednesday, March 4th, 2015
New and Noteworthy P.E.I. announces their hepatitis C strategy Community-based program successful at linking people to Hep C testing and care
Posted On: Tuesday, February 24th, 2015
New and Noteworthy Vertical transmission of hepatitis C estimated to occur in over 5% of births in women with hepatitis C According to a systematic review on vertical transmission of hepatitis C, the estimated risk for transmission of hepatitis C to the fetus during pregnancy is 5.8%, reported researchers in Clinical Infectious Diseases. With hepatitis… Read more »
Posted On: Wednesday, February 11th, 2015
New and Noteworthy Screening Canadians born between 1945 and 1965 could be cost effective According to a modelling study, one-time screening for people 25 to 64 or 45 to 64 years of age could be cost-effective, reported researchers in the Canadian Medical Association Journal. For both age ranges the researchers modelled four options: No screening… Read more »
Posted On: Wednesday, February 11th, 2015
Posted On: Wednesday, January 28th, 2015
Friday, February 6, 2015 @1:00pm EST Join us for this webinar where we will present an overview of the 2012-2013 HIV and HCV Performance Measurement Reports. The reports cover activities funded through the national Voluntary Sector Fund; Knowledge Exchange Fund; On-Reserve First Nations, Inuit and Métis Communities HIV/AIDS Project Fund;and the Hepatitis C Prevention, Support… Read more »
Posted On: Wednesday, January 21st, 2015
New and noteworthy Holkira Pak (AbbVie 3D combination) approved by Health Canada Holkira Pak cures Hep C in most liver transplant recipients Birth cohort screening more effective than risk-based testing in U.S.
Posted On: Wednesday, January 14th, 2015
Pacific Hepatitis C Network’s Annual General Meeting is taking place Monday, January 26, 3 – 5 pm. This AGM is our first completely online AGM and we are looking forward to having as many of you attending as possible! It has been hard to have full participation in the past because our PHCN members –… Read more »
Posted On: Friday, January 9th, 2015
January Updates Community of Practice: If you haven’t had a chance to join in our Community of Practice, then now is the time to start some new trends. The CoP is a community of frontline workers across the province who are interested in Mental Health and Substance Use. This is a forum to share your… Read more »
Posted On: Wednesday, January 7th, 2015
Please note: HepCBC wants to clarify that the “speculative price” in Canada for AbbVie’s interferon-free HolkiraTM Pak given on page 3 of our January, 2015 Bulletin is not official, and doesn’t reflect any real pricing. We can say that on or before January 16th, we will be able to post the actual price on our… Read more »
Posted On: Wednesday, January 7th, 2015
Response to Treatment by Prevention Article The Globe and Mail article: B.C. medical researchers offer treatment by prevention for hepatitis C PHCN recognizes treatment as prevention (TasP) as the strategy of choice for people who use injection/inhalation drugs, who, as a group, have the highest rate of new HCV infections. Treatment as prevention is an… Read more »
Posted On: Wednesday, January 7th, 2015
New and Noteworthy: Telaprevir discontinued in Canada Telaprevir (Incivek) has been discontinued in Canada as of January 1, 2015. Telaprevir is a first generation direct-acting anti-viral medication that is used in combination with peg-interferon and ribavirin to treat hepatitis C. The availability of new treatments for hepatitis C has resulted in a decreased demand for… Read more »
